Home
Cancer Biomarkers
Biomarkers by Organ & Phase
Antibodies
Endocrine Antibodies
Adrenal Antibodies
Glutamic Acid Decarboxylase (GAD) Antibodies
Gastric Parietal Cell Antibodies (GPC)
Islet Cell Antibodies (ICA)
Ovary Antibodies
Testis Antibodies
Gastrointestinal Antibodies
Endomysial Antibodies
Liver Cytosolic Antigen Type 1 Autoantibodies (LC-1)
Liver/Kidney Microsomal (LKM) Antibodies
Liver Disease
Mitochondrial Antibodies
Smooth Muscle Antibodies
Nervous
Amphiphysin
CV2 (CRMP5)
Hu (ANNA1)
Ma2 (Ta)
Myelin Associated Glycoprotein (MAG) Antibody
Oligoclonal Band pattern
Tr (PCA-Tr)
Yo (PCA1)
Nuclear
Mixed Patterns
Nucleolar Patterns
Others
Anti-neutrophil Cytoplasmic Antibodies (ANCA)
Cardiac Muscle Antibody
Glomerular basement membrane antibody (GBM)
Skeletal Muscle (Striational) antibody
Skin: Epidermal Antibodies
Skin: Pemphigus Antibodies
Autoimmune Diseases
ANA
Cytoplasmic Patterns
Mitotic Patterns
Nuclear Patterns
Short Reads
News
Contact
Alphyn Biologics Reports Positive Pediatric Results from Phase 2a Atopic Dermatitis Trial
2 June, 2023
Visus Therapeutics Presents Topline Clinical Data from Phase 3 Pivotal BRIO-I Trial of BRIMOCHOL™ PF for the Treatment of Presbyopia at Eyecelerator
2 June, 2023
Nanox scores clearance for cloud-connected X-ray bed after years of FDA review
2 June, 2023
Sarepta, days out from critical FDA meeting, lists questions expected at gene therapy AdComm
2 June, 2023
Lilly’s Donanemab Slows Cognitive, Functional Decline in Phase III Alzheimer’s Study
2 June, 2023
Novo Nordisk’s Hemophilia Hopeful Hits FDA Roadblock, Company Cuts Wegovy Supply
1 June, 2023
Next round of KRAS drugs stretch for their 4-minute mile in the footsteps of Amgen and Mirati
1 June, 2023
Travere fails to beat off-label blood pressure drug in phase 3 but plans talks with FDA anyway
1 June, 2023
Roche creates organoid research institute to shake up drug discovery and development
1 June, 2023
FDA encourages decentralized trials with new guidance
1 June, 2023
BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle
31 May, 2023
Selecta lays off 25% as unpartnered gene therapies take a back seat
31 May, 2023
NGM hunts for light at end of tunnel as mid-phase NASH trial hits primary goal
31 May, 2023
Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal
31 May, 2023
Regeneron Diversifies Portfolio as Eylea Revenue Takes a Hit
31 May, 2023
FDA Approves Fabry Disease Treatment from Chiesi, Protalix
30 May, 2023
Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup
30 May, 2023
FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More
30 May, 2023
Opinion: Hope on the Horizon for Sjogren’s Syndrome
30 May, 2023
Biopharma Bets Big on Antibody-Drug Conjugates
30 May, 2023
Will Advancements in AI Lead to Job Loss in Biotech?
29 May, 2023
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
29 May, 2023
Roche Cuts 165 Jobs in New Jersey, Scales Back COVID-19 Portfolio
29 May, 2023
Amgen Drops Drug Delivery Partnership, Targets Crohn’s Disease with TScan Pact
29 May, 2023
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
28 May, 2023
Senate Health Committee Seeks to Rein in Drug Prices with Four New Bills
28 May, 2023
Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Committee
28 May, 2023
Convicted ‘Pharma Bro’ Shkreli’s Vyera Files for Bankruptcy
28 May, 2023
FDA Advisory Panel Strongly Backs Perrigo’s OTC Birth Control Pill
28 May, 2023
Viking Therapeutics Clears Mid-Stage NASH Trial
27 May, 2023
Astellas Wins FDA Approval for Hot Flash Treatment in Menopausal Women
27 May, 2023
Companies Bank on Psychedelics as Treatments for Mental Health Disorders
27 May, 2023
AstraZeneca Expands ADC Portfolio with $600M Deal with LaNova
27 May, 2023
GSK’s Phase III Meningococcal Vaccine Results Heat Up Race with Pfizer
27 May, 2023
Supreme Court Denies Teva’s Challenge to $235M GSK Award in Patent Dispute
26 May, 2023
Astellas, Sony Team on Novel ADC Platform for Oncology
26 May, 2023
CVS Health Winding Down Clinical Trial Business
26 May, 2023
Lilly’s Prevail, Doudna’s Scribe Partner on Genetic Treatments for Neuro Diseases
26 May, 2023
Roche’s MS Drug Hits Phase II Mark, Rivals Remain Under Clinical Holds
26 May, 2023
AbbVie Adds Crohn’s Disease to Rinvoq’s Growing List of Indications
25 May, 2023
FDA Panel Backs Pfizer’s Maternal RSV Vaccine Despite Safety Concerns
25 May, 2023
Update: Takeda Cuts Jobs in California Following Massachusetts Layoffs
25 May, 2023
ElevateBio Takes Title of Largest 2023 Funding with $401M Series D
25 May, 2023
Update: FDA Delays Decision on Sarepta’s DMD Gene Therapy
25 May, 2023
US Appeals Court Panel Questions FDA Due Diligence on Abortion Pill
25 May, 2023
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
25 May, 2023
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
25 May, 2023
FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug
24 May, 2023
Propanc Biopharma Announces Reverse Stock Split – May 23, 2023
24 May, 2023
TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch and Platform Extension
24 May, 2023
Innate Pharma to Participate in Upcoming June 2023 Investor Conferences
24 May, 2023
Ironwood to Pay $1B to Acquire VectivBio, Late-Stage Digestive Therapy
24 May, 2023
Spago Nanomedical has Submitted Application to Start Tumorad(R) Clinical Phase I/IIa Study
23 May, 2023
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock – May 23, 2023
23 May, 2023
Gilead’s R&D spending spiked 25% in Q1, shortening investment gap with peers
11 May, 2023
Lilly’s Mounjaro Poised to Challenge Novo’s Wegovy in Obesity
11 May, 2023
New type of RNA degrader lowers COVID-19 viral load in mice, opening path to new drug class
11 May, 2023
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model
11 May, 2023
FDA Greenlights Pfizer’s Pneumococcal Vaccine in Infants and Children
10 May, 2023
Pfizer Cuts Mid-Stage Candidates Amid Declining Revenues
10 May, 2023
Astellas to Buy Iveric Bio for $5.9B in Age-Related Blindness Play
10 May, 2023
FDA Greenlights First Bi-Monthly Injectable for Schizophrenia, Bipolar 1 Disorder
10 May, 2023
FDA Panel Supports Narrow Lynparza Label for Prostate Cancer
10 May, 2023
Ovid snaps up Rock2 inhibitor from Sam Waksal-led biotech, continuing climb through neurological terrain
10 May, 2023
Sanofi, Flatiron Health in pact to redesign oncology clinical trials
10 May, 2023
FDA Questions Efficacy of Merck-AstraZeneca’s Lynparza Ahead of Adcomm
10 May, 2023
Humira Sales Down 25% as AbbVie Cuts Two Programs
10 May, 2023
Sanofi Cleans House, Cuts Assets from Principia and Ablynx Buyouts
10 May, 2023
Biopharma feels momentary relief as Supreme Court preserves abortion drug access—for now
9 May, 2023
AstraZeneca dumps $855M, near-approval rare disease drug after talks with regulators
9 May, 2023
Cerevel to change up CEO as 7 data readouts near showdown
9 May, 2023
Veracyte Announces Release of Inaugural ESG Report
9 May, 2023
Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)
9 May, 2023
RAPT Therapeutics Announces the Appointment of Michael Listgarten as General Counsel
9 May, 2023
Industry Seeks to Stimulate Innovation Through Grant Programs
9 May, 2023
Caforio Out, Boerner In as BMS Sees Slight Decline with Generic Competition
9 May, 2023
FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS
4 May, 2023
Antibodies Against Zika Virus Help Prevent Infection
23 November, 2022
Roche’s Alzheimer’s Drug Gantenerumab Fails, Raises Questions About Amyloid Based Medicine
15 November, 2022
Astrazeneca Clearing Pipeline, Abandons Solid Tumor and Kidney Disease Prospects
11 November, 2022
